Modulation of ovarian function by an oral contraceptive containing 30 μg ethinyl estradiol in combination with 2.00 mg dienogest-Reference-Cited by-同舟云学术

Modulation of ovarian function by an oral contraceptive containing 30 μg ethinyl estradiol in combination with 2.00 mg dienogest

Published:1997-09 Issue:3 Volume:56 Page:185-191
ISSN:0010-7824
Container-title:Contraception
language:en
Short-container-title:Contraception

Author:

Spona J.,Feichtinger W.,Kindermann C.,Moore C.,Mellinger U.,Walter F.,Gräser T.

Publisher

Elsevier BV

Subject

Obstetrics and Gynaecology,Reproductive Medicine

Reference22 articles.

1. Combined oral contraceptives. A statement by the committee on Safety of Drugs;Committee on Safety of Drugs;Br Med J,1970

2. RCOG statement on oral contraceptives (letter);Jeffcoat;Br Med J,1970

3. Oral contraceptives, clotting factors and thrombosis;Meade;Am J Obstet Gynecol,1982

4. Haemostatic system changes induced by 50 μg and 30 μg oestrogen/progestin oral contraceptives. Modification of oestrogen effects by levonorgestrel;Sabra;J Reprod Med,1983

5. Comparative studies of 30 μg ethinyl estradiol combined with gestodene and desogestrel on blood coagulation, fibrinolysis, and platelets;Daly;Am J Obstet Gynecol,1990

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacodynamics of combined estrogen-progestin oral contraceptives 3. Inhibition of ovulation;Expert Review of Clinical Pharmacology;2018-11-02

2. Systematic Review of Ovarian Activity and Potential for Embryo Formation and Loss during the Use of Hormonal Contraception;The Linacre Quarterly;2018-11

3. Progestins for Contraception;Clinical Obstetrics & Gynecology;2014-12

4. New and emerging contraceptives: a state-of-the-art review;International Journal of Women's Health;2014-02

5. Pituitary, ovarian and additional contraceptive effects of an estradiol-based combined oral contraceptive: results of a randomized, open-label study;Contraception;2013-02